TY - JOUR
T1 - Syphilis
T2 - an increasingly common sight among pediatricians?
AU - Labrusco, Miguel
AU - Briosa, Filipa
AU - Paulos, Lígia
AU - Lima, Sofia
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) and Portuguese Journal of Pediatrics 2021.
PY - 2021
Y1 - 2021
N2 - A 15-year-old female was admitted to the pediatric emergency department reporting a one-week history of pruritic rash involving palmoplantar surfaces of the hands and one foot. She was apyretic and reported no constitutional or rheumatologic symptoms. Upon questioning, she mentioned a painless lesion in the vulvar region one month beforehand, with spontaneous remission shortly afterward. Relevant previous history included unprotected sexual intercourse with multiple partners since she was 12 years old. Physical examination revealed multiple symmetric erythematous round macules (1-2 cm in diameter) involving both palms and the sole of the right foot (Fig. 1) as well as multiple vulvar ulcers (Fig. 2). Serological testing was positive for the venereal disease research laboratory (VDRL) test and Treponema pallidum hemagglutination assay (TPHA), confirming the diagnosis of secondary syphilis. Further investigation revealed negative serological testing for hepatitis B and C and for human immunodeficiency virus (HIV). Polymerase chain reaction of the endocervical exudate for both Chlamydia trachomatis and Neisseria gonorrhoeae was also negative. She was treated with a single dose of 2.4 million units of intramuscular penicillin and referred to the outpatient clinic. The disease was properly notified, and all of the partners were advised. Upon revaluation, she had experienced a significant clinical improvement, with the remission of all the mentioned lesions, VDRL with lower levels, positive TPHA, and HIV remaining negative six months after treatment. Syphilis is an infection caused by the spirochete Treponema pallidum.1,2 It continues to cause significant morbidity and mortality worldwide, including in adolescents. In 2018, in Europe, 13% of confirmed infections were in people aged 15 to 24 years-old.3,4 In Portugal, the incidence of syphilis has been rising since 2014.3 Without treatment, it can manifest as a three-stage disease.2 The observed macular rash is characteristic of secondary syphilis and should elicit the diagnosis, especially when preceded by the characteristic chancre of primary syphilis.2 Diagnosis should be confirmed with both treponemal and nontreponemal testing.2 Parentally-delivered penicillin G is the treatment of choice in all stages of syphilis.
AB - A 15-year-old female was admitted to the pediatric emergency department reporting a one-week history of pruritic rash involving palmoplantar surfaces of the hands and one foot. She was apyretic and reported no constitutional or rheumatologic symptoms. Upon questioning, she mentioned a painless lesion in the vulvar region one month beforehand, with spontaneous remission shortly afterward. Relevant previous history included unprotected sexual intercourse with multiple partners since she was 12 years old. Physical examination revealed multiple symmetric erythematous round macules (1-2 cm in diameter) involving both palms and the sole of the right foot (Fig. 1) as well as multiple vulvar ulcers (Fig. 2). Serological testing was positive for the venereal disease research laboratory (VDRL) test and Treponema pallidum hemagglutination assay (TPHA), confirming the diagnosis of secondary syphilis. Further investigation revealed negative serological testing for hepatitis B and C and for human immunodeficiency virus (HIV). Polymerase chain reaction of the endocervical exudate for both Chlamydia trachomatis and Neisseria gonorrhoeae was also negative. She was treated with a single dose of 2.4 million units of intramuscular penicillin and referred to the outpatient clinic. The disease was properly notified, and all of the partners were advised. Upon revaluation, she had experienced a significant clinical improvement, with the remission of all the mentioned lesions, VDRL with lower levels, positive TPHA, and HIV remaining negative six months after treatment. Syphilis is an infection caused by the spirochete Treponema pallidum.1,2 It continues to cause significant morbidity and mortality worldwide, including in adolescents. In 2018, in Europe, 13% of confirmed infections were in people aged 15 to 24 years-old.3,4 In Portugal, the incidence of syphilis has been rising since 2014.3 Without treatment, it can manifest as a three-stage disease.2 The observed macular rash is characteristic of secondary syphilis and should elicit the diagnosis, especially when preceded by the characteristic chancre of primary syphilis.2 Diagnosis should be confirmed with both treponemal and nontreponemal testing.2 Parentally-delivered penicillin G is the treatment of choice in all stages of syphilis.
KW - Adolescent
KW - Skin Manifestations
KW - Syphilis/diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85112515958&partnerID=8YFLogxK
U2 - 10.25754/pjp.2021.20139
DO - 10.25754/pjp.2021.20139
M3 - Article
AN - SCOPUS:85112515958
SN - 2184-3333
VL - 52
SP - 235
EP - 236
JO - Portuguese Journal of Pediatrics
JF - Portuguese Journal of Pediatrics
IS - 3
ER -